Skip to content
Recall Observatory FDA recall evidence

Drug product

Imipramine Pamoate Capsules 125 mg, 30-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 UNited States. Manufactured by: Lupin Limited, Pithampur, (M.P.) 454 775 India NDC# 68180-316-06

D-0027-2022

October 08, 2021

Class II

Product summary

Firm
Lupin Pharmaceuticals Inc.
Event
Event 88838
Status
Terminated
Classification
Class II
Quantity
1,902 bottles
Official record key
drug-enforcement:D-0027-2022

Official wording

Reason: Out of specification result observed in a dissolution test at the 9-month long term stability time point.

Code information: lot H002205, exp. date 08/2023

Distribution pattern: Distributed Nationwide in the USA.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out of specification